SCHEMBL18766902

SCHEMBL18766902

CCNCC1CCN(C2(Cc3cccc(OC)c3)CC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.46
▸ KMT2A Q03164 7/20 0.46
▸ MAPT P10636 3/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ LMNA P02545 3/20 0.43
▸ HTR1A P08908 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ EED O75530 1/20 0.42
▸ PKM P14618 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18766901 0.82 MAPT (0.46) MEN1KMT2AMAPTNPC1GAA
SCHEMBL18766903 0.76 KMT2A (0.43) MEN1KMT2AMAPTNPC1GAA
SCHEMBL18766904 0.71 KDM4E (0.44) MEN1KMT2AMAPTNPC1KDM4E
SCHEMBL11094660 0.71 MAPT (0.54) MEN1KMT2AMAPTGAAL3MBTL1
SCHEMBL18768348 0.70 MEN1 (0.67) MEN1KMT2AHTR1ASLC6A4
SCHEMBL1965727 0.69 CHRM2 (0.60) MEN1KMT2ANPC1KDM4EALDH1A1
Ethylene SCHEMBL11094451 0.69 MAPT (0.52) MEN1KMT2AMAPTGAAL3MBTL1
SCHEMBL8422440 0.68 SLC6A2 (0.41) MEN1KMT2AMAPTLMNASLC6A4
SCHEMBL25525962 0.66 TAAR1 (0.50) MEN1KMT2AL3MBTL1
SCHEMBL8279674 0.66 CHRM2 (0.68) MEN1KMT2AGAASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017066705-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE AGAINST STRESS GRANULES AQUINNAH PHARMACEUTICALS, INC. (US) 2017-04-20 — — WO disclosed
Send feedback